Haemate HS

von Willebrand factor/vIII concentrate · CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Haemate HS, covering 2012-01-05 to 2012-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis [Phase 2]